Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 12-1997 | 12-1996 | 12-1995 | 12-1994 | |
| Sales | 26,866,500 | 2,557,700 | 2,559,890 | 2,474,400 | 2,128,678 |
| Cost of Goods | 8,784,000 | 883,080 | 899,130 | 896,500 | N/A |
| Gross Profit | 18,082,500 | 1,674,620 | 1,660,750 | 1,577,900 | 2,128,678 |
| Operating Expenses | 14,982,000 | 1,213,210 | 1,250,210 | 1,272,400 | 0 |
| Operating Income | 3,100,500 | 461,490 | 410,680 | 306,000 | 2,128,678 |
| Interest Expense | 273,000 | 49,840 | 59,720 | 0 | 0 |
| Other Income | 2,782,500 | 65,990 | 82,940 | 82,700 | 0 |
| Pre-tax Income | 5,610,000 | 477,640 | 433,900 | 388,700 | 2,128,678 |
| Income Tax | 2,005,500 | 143,500 | 124,780 | 106,900 | N/A |
| Net Income Continuous | 364,874 | 317,864 | 276,326 | 280,030 | 225,397 |
| Net Income | $3,613,500 | $334,130 | $309,630 | $281,800 | $225,397 |
| EPS Basic Total Ops | 0.05 | 0.04 | 0.04 | 0.04 | 0.03 |
| EPS Basic Continuous Ops | 0.05 | 0.04 | 0.04 | 0.04 | 0.03 |
| EPS Diluted Total Ops | 0.05 | 0.04 | 0.04 | 0.04 | 0.03 |
| EPS Diluted Continuous Ops | 0.05 | 0.04 | 0.04 | 0.04 | 0.03 |
| EBITDA(a) | $3,100,500 | $461,490 | $410,680 | $306,000 | $2,128,678 |